A historical perspective on sepsis

American Journal of Pathology

Volumn 181, Issue 1, 2012, Pages 2-7

  Ward, Peter A ^a   Bosmann, Markus ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; DROTRECOGIN;

APOPTOSIS; B LYMPHOCYTE; BLEEDING; CLINICAL TRIAL (TOPIC); DENDRITIC CELL; HISTORY; HUMAN; NATURAL KILLER CELL; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEPSIS; T LYMPHOCYTE;

EID: 84862669323     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.05.003     Document Type: Article

References (43)

1. Zingarelli B, Piraino G, Hake PW, O'Connor M, Denenberg A, Fan H, Cook JA: Peroxisome proliferator-activated receptor {delta} regulates inflammation via NF-{kappa}B signaling in polymicrobial sepsis. Am J Pathol 2010, 177:1834-1847
2. Chorny A, Delgado M: Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1. Am J Pathol 2008, 172:1297-1307
3. Laudes IJ, Guo RF, Riedemann NC, Speyer C, Craig R, Sarma JV, Ward PA: Disturbed homeostasis of lung intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 during sepsis. Am J Pathol 2004, 164:1435-1445
4. Wen H, Hogaboam CM, Gauldie J, Kunkel SL: Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile. Am J Pathol 2006, 168:1940-1950
5. Cuenca J, Martín-Sanz P, Alvarez-Barrientos AM, Boscá L, Goren N: Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis. Am J Pathol 2006, 169:1567-1576
6. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, Barrette TR, Shankar-Sinha S, Sarma VJ, Padgaonkar VA, Ward PA: Molecular signatures of sepsis: multiorgan gene expression profiles of systemic inflammation. Am J Pathol 2001, 159:1199-1209
7. Biswal S, Remick DG: Sepsis: redox mechanisms and therapeutic opportunities. Antioxid Redox Signal 2007, 9:1959-1961
8. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992, 20:864-874
9. Speyer CL, Gao H, Rancilio NJ, Neff TA, Huffnagle GB, Sarma JV, Ward PA: Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am J Pathol 2004, 165:2187-2196
10. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, Srivastava A, Swanson PE, Green JM, Hotchkiss RS: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 2011, 306:2594-2605
11. Ward PA: Immunosuppression in sepsis. JAMA 2011, 306:2618-2619
12. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA: The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009, 15:496-497
13. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29:1303-1310
14. Quartin AA, Schein RM, Kett DH, Peduzzi PN; Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group: Magnitude and duration of the effect of sepsis on survival. JAMA 1997, 277:1058-1063
15. Iwashyna TJ, Ely EW, Smith DM, Langa KM: Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010, 304:1787-1794
16. Semmler A, Frisch C, Debeir T, Ramanathan M, Okulla T, Klockgether T, Heneka MT: Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model. Exp Neurol 2007, 204:733-740
17. Angus DC: The lingering consequences of sepsis: a hidden public health disaster? JAMA 2010, 304:1833-1834
18. Benjamim CF, Lundy SK, Lukacs NW, Hogaboam CM, Kunkel SL: Reversal of long-term sepsis-induced immunosuppression by dendritic cells. Blood 2005, 105:3588-3595
19. Marshall JC: Sepsis: rethinking the approach to clinical research. J Leukoc Biol 2008, 83:471-482
20. Sandeman SR, Howell CA, Mikhalovsky SV, Phillips GJ, Lloyd AW, Davies JG, Tennison SR, Rawlinson AP, Kozynchenko OP: Inflammatory cytokine removal by an activated carbon device in a flowing system. Biomaterials 2008, 29:1638-1644
21. DiLeo MV, Fisher JD, Burton BM, Federspiel WJ: Selective improvement of tumor necrosis factor capture in a cytokine hemoadsorption device using immobilized anti-tumor necrosis factor. J Biomed Mater Res B Appl Biomater 2011, 96:127-133
22. Riewald M, Ruf W: Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling. J Biol Chem 2005, 280:19808-19814
23. Angus DC: Drotrecogin alfa (activated) . . . a sad final fizzle to a roller-coaster party. Crit Care 2012, 16:107
24. Angus DC: The search for effective therapy for sepsis: back to the drawing board? JAMA 2011, 306:2614-2615
25. Remick DG, Ward PA: Evaluation of endotoxin models for the study of sepsis. Shock 2005, 24 Suppl 1:7-11
26. Bosmann M, Russkamp NF, Patel VR, Zetoune FS, Sarma JV, Ward PA: The outcome of polymicrobial sepsis is independent of T and B cells. Shock 2011, 36:396-401
27. Kelly-Scumpia KM, Scumpia PO, Weinstein JS, Delano MJ, Cuenca AG, Nacionales DC, Wynn JL, Lee PY, Kumagai Y, Efron PA, Akira S, Wasserfall C, Atkinson MA, Moldawer LL: B cells enhance early innate immune responses during bacterial sepsis. J Exp Med 2011, 208:1673-1682
28. Rauch PJ, Chudnovskiy A, Robbins CS, Weber GF, Etzrodt M, Hilgendorf I, Tiglao E, Figueiredo JL, Iwamoto Y, Theurl I, Gorbatov R, Waring MT, Chicoine AT, Mouded M, Pittet MJ, Nahrendorf M, Weissleder R, Swirski FK: Innate response activator B cells protect against microbial sepsis. Science 2012, 335:597-601
29. Delano MJ, Thayer T, Gabrilovich S, Kelly-Scumpia KM, Winfield RD, Scumpia PO, Cuenca AG, Warner E, Wallet SM, Wallet MA, O'Malley KA, Ramphal R, Clare-Salzer M, Efron PA, Mathews CE, Moldawer LL: Sepsis induces early alterations in innate immunity that impact mortality to secondary infection. J Immunol 2011, 186:195-202
30. Ward PA: The harmful role of C5a on innate immunity in sepsis. J Innate Immun 2010, 2:439-445
31. Etogo AO, Nunez J, Lin CY, Toliver-Kinsky TE, Sherwood ER: NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis. J Immunol 2008, 180:6334-6345
32. Chiche L, Forel JM, Thomas G, Farnarier C, Vely F, Blery M, Papazian L, Vivier E: The role of natural killer cells in sepsis. J Biomed Biotechnol 2011, 2011:986491
33. Scumpia PO, McAuliffe PF, O'Malley KA, Ungaro R, Uchida T, Matsumoto T, Remick DG, Clare-Salzler MJ, Moldawer LL, Efron PA: CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis. J Immunol 2005, 175:3282-3286
34. Ding Y, Chung CS, Newton S, Chen Y, Carlton S, Albina JE, Ayala A: Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock 2004, 22:137-144
35. Pene F, Courtine E, Ouaaz F, Zuber B, Sauneuf B, Sirgo G, Rousseau C, Toubiana J, Balloy V, Chignard M, Mira JP, Chiche JD: Toll-like receptors 2 and 4 contribute to sepsis-induced depletion of spleen dendritic cells. Infect Immun 2009, 77:5651-5658
36. Riedemann NC, Guo RF, Laudes IJ, Keller K, Sarma VJ, Padgaonkar V, Zetoune FS, Ward PA: C5a receptor and thymocyte apoptosis in sepsis. FASEB J 2002, 16:887-888
37. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP, Buchman TG, Karl IE: Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 2001, 166:6952-6963
38. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150
39. Peck-Palmer OM, Unsinger J, Chang KC, Davis CG, McDunn JE, Hotchkiss RS: Deletion of MyD88 markedly attenuates sepsis-induced T and B lymphocyte apoptosis but worsens survival. J Leukoc Biol 2008, 83:1009-1018
40. Budd RC. Death receptors couple to both cell proliferation and apoptosis. J Clin Invest 2002 Feb;109:437-441
41. Hotchkiss RS, Coopersmith CM, Karl IE: Prevention of lymphocyte apoptosis-a potential treatment of sepsis? Clin Infect Dis 2005;41 Suppl 7:S465-S469
42. Kasten KR, Prakash PS, Unsinger J, Goetzman HS, England LG, Cave CM, Seitz AP, Mazuski CN, Zhou TT, Morre M, Hotchkiss RS, Hildeman DA, Caldwell CC: Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. Infect Immun 2010, 78:4714-4722
43. Goyert SM, Silver J: Editorial: PD-1, a new target for sepsis treatment: better late than never. J Leukoc Biol 2010, 88:225-226